Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial

Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial

Background: The number of people with dementia is increasing, with huge challenges for society and health-care systems. There are no disease-modifying therapies available. There is, therefore, an urgent need to identify strategies to reduce the risk of developing dementia. Anthocyanins are a class o...

Full description

Bibliographic Details
Main Authors: Khadija Khalifa, Anne Katrine Bergland, Hogne Soennesyn, Ketil Oppedal, Ragnhild Oesterhus, Ingvild Dalen, Alf Inge Larsen, Tormod Fladby, Helen Brooker, Keith A. Wesnes, Clive Ballard, Dag Aarsland
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Neurology
Subjects:
anthocyanins
mild cognitive impairment
dementia
randomized controlled trial
intervention
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00916/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.00916/full

Similar Items